Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Laurent Rigoreau.

Newcastle AuthorsTitleYearFull text
Stephanie Myers
Duncan Miller
Dr Lauren Molyneux
Dr Mercedeh Arasta
Dr Ruth Bawn
et al.
Identification of a novel orally bioavailable ERK5 inhibitor with selectivity over p38α and BRD42019
Stephanie Myers
Dr Ruth Bawn
Betty Cottyn
Dr Lauren Molyneux
Dr Celine Cano
et al.
High-throughput screening and hit validation of extracellular-related kinase 5 (ERK5) inhibitors2016
Tristan Reuillon
Duncan Miller
Stephanie Myers
Dr Lauren Molyneux
Dr Celine Cano
et al.
Pyrrolcarboxamide Derivatives for the Inhibition of ERK52016
Dr Ruth Bawn
Tristan Reuillon
Emeritus Professor Bernard Golding
Professor Roger Griffin
Dr Ian Hardcastle
et al.
Development of extracellular signal-regulated kinase 5 (ERK5) inhibitors for anti-cancer therapy2014
Dr Kappusamy Saravanan
Dr Celine Cano
Professor Nicola Curtin
Emeritus Professor Bernard Golding
Dr Karen Haggerty
et al.
Identification of potent water-soluble DNA-dependent protein kinase (DNA-PK) inhibitors using a small-molecule library approach [abstract]2008
Michael Batey
Dr Laurent Rigoreau
Professor Roger Griffin
Professor Herbie Newell
Professor Nicola Curtin
et al.
Potent in vitro and in vivo radiosensitisation by the selective DNA-dependent protein kinase inhibitor KU-0060648 [abstract]2008
Jonathan Hollick
Dr Laurent Rigoreau
Dr Celine Cano
Professor Nicola Curtin
Emeritus Professor Bernard Golding
et al.
Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase2007
Dr Ian Hardcastle
Professor Nicola Curtin
Justin John James Leahy
Martin Stockley
Emeritus Professor Bernard Golding
et al.
Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approach2005
Professor Roger Griffin
Emeritus Professor Bernard Golding
Sophie Guiard
Dr Ian Hardcastle
Justin John James Leahy
et al.
Selective benzopyranone and pyrimido[2,1-alpha]isoquinolin-4-one inhibitors of DNA-dependent protein kinase: Synthesis, structure-activity studies, and radiosensitization of a human tumor cell line in vitro2005
Justin John James Leahy
Emeritus Professor Bernard Golding
Professor Roger Griffin
Dr Ian Hardcastle
Dr Laurent Rigoreau
et al.
Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries2004
Jonathan Hollick
Emeritus Professor Bernard Golding
Dr Ian Hardcastle
Dr Laurent Rigoreau
Professor Roger Griffin
et al.
2,6-disubstituted pyran-4-one and thiopyran-4-one inhibitors of DNA-dependent protein kinase (DNA-PK)2003
Jonathan Hollick
Emeritus Professor Bernard Golding
Professor Roger Griffin
Dr Ian Hardcastle
Justin John James Leahy
et al.
Application of combinatorial chemistry for the identification of pyran-4-one and thiopyran-4-one inhibitors of DNA-dependent protein kinase2002
Professor Roger Griffin
Dr Ian Hardcastle
Dr Laurent Rigoreau
Martin Stockley
Justin John James Leahy
et al.
Cassette dosing iv and ip of novel DNA dependent protein kinase inhibitors2002
Professor Roger Griffin
Dr Ian Hardcastle
Dr Laurent Rigoreau
Martin Stockley
Justin John James Leahy
et al.
High throughput pharmacokinetics of novel DNA-dependent protein kinase inhibitors2002
Dr Stephany Veuger
Professor barbara Durkacz
Emeritus Professor Bernard Golding
Professor Roger Griffin
Professor Herbie Newell
et al.
Radiosensitization by novel inhibitors of PARP, PI, and DNA-PK, NU7026, in vitro2001
Martin Stockley
Professor William Clegg
Emeritus Professor Bernard Golding
Nicola Martin
Dr Laurent Rigoreau
et al.
Synthesis, crystal structure determination, and biological properties of the DNA-dependent protein kinase (DNA-PK) inhibitor 3-cyano-6-hydrazonomethyl-5-(4-pyridyl)pyrid-[1H]-2-one (OK-1035)2001